Program Description:

The use of ketamine has gained a lot of attention in recent years as a potential treatment for psychiatric disorders.  However, research around the safe use of ketamine for such conditions has not yet been well-established.  Many factors need to be considered when assessing the use of ketamine for psychiatric conditions.

This intermediate-level presentation explores three themes relating to ketamine. The presentation begins with a review of the history that led to research on the therapeutic use of ketamine for the treatment of mental disorders. Then we  focus on efficacy data for ketamine, primarily considering utility for major depressive disorder. We also discuss non-approved uses where research exists. Finally, the review discusses some of the issues that clinicians face when considering whether to recommend treatment with ketamine.

Clinical Objectives:

At the close of this presentation, attendees should be able to:

1. Identify ways in which the research on pathophysiology informed the development of randomized controlled trials examining ketamine efficacy

2. Analyze the strength and weaknesses in data on safety and efficacy from randomized control trials

3. Discuss key issues to consider when evaluating the suitability of individual patients for treatment with ketamine

Event Details:

CE Information

• 2 CE: Approved for CE for Psychologists in all states, Social Workers in New York, Virginia, and Washington, DC, and CHES professionals. Many licensing boards accept CE from APA approved sponsors as well as for trainings approved by boards in other jurisdictions. Please review this chart to see whether your state approves CE for this training.

Cost:

• $50 – Individual with CE or CME. 
• $40 – Non-CE Participants, CHES professionals and Students. 
• Free for ADAA members: The Ross Center, in collaboration with ARC Health, is pleased to provide ADAA members access to continuing education opportunities at no cost.  

Registration:

REGISTER HERE for HOMESTUDY RECORDING.

Agenda: Click here to view

Presented by: Daniel Pine, MD

Dr. Danny Pine is a psychiatrist specializing in the treatment of anxiety and mood disorders in children and adolescents. He is widely acknowledged as one of the world’s top anxiety researchers, and applies his extensive knowledge through diagnosis and treatment of young patients at The Ross Center.

TESTIMONIALS:

“Dr Pine is extremely knowledgeable, and the content followed the stated objectives.”

“I learned more about the potential side effects of ketamine and the different ways it is usually administered.”

“Excellent presentation.”

For more information contact: [email protected]

The Ross Center for Anxiety and Related Disorders, LLC, is approved by the American Psychological Association to sponsor continuing education for psychologists. The Ross Center maintains responsibility for this program and its content. The Ross Center for Anxiety and Related Disorders, LLC, is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0105. Ross Management Services, LLC is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0701 There is no conflict of interest or commercial support for this program.